|
|
|
Volumn 99, Issue 3, 1997, Pages 249-255
|
|
IBC's 2nd international conference on protease inhibitors: Novel therapeutic applications and development, Washington DC, USA, 24-26 February 1997
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMPRENAVIR;
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
ANTISENSE OLIGONUCLEOTIDE;
ASPARTIC PROTEINASE;
ASPARTIC PROTEINASE INHIBITOR;
BACTERIAL ENZYME;
BATIMASTAT;
CA 074;
CATHEPSIN;
CYSTEINE PROTEINASE;
CYSTEINE PROTEINASE INHIBITOR;
FLUOROMETHYLKETONE DERIVATIVE;
INDINAVIR;
KALLIKREIN;
KETONE DERIVATIVE;
LEUKOCYTE ELASTASE;
LOPINAVIR;
MARIMASTAT;
METALLOPROTEINASE;
METALLOPROTEINASE INHIBITOR;
N (1 HYDROXY 2 NAPHTHOYL)ARGINYLPROLINAMIDE;
NELFINAVIR;
PROTEINASE INHIBITOR;
RITONAVIR;
SAQUINAVIR;
SERINE PROTEINASE;
SERINE PROTEINASE INHIBITOR;
TISSUE INHIBITOR OF METALLOPROTEINASE;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
VE 13045;
ALLERGY;
ARTHRITIS;
ASTHMA;
CANCER THERAPY;
CLINICAL TRIAL;
CONFERENCE PAPER;
DRUG DESIGN;
DRUG RESISTANCE;
DRUG STRUCTURE;
HUMAN;
MALARIA;
NONHUMAN;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PROTEINASE INHIBITION;
BACTERIA (MICROORGANISMS);
HUMAN IMMUNODEFICIENCY VIRUS;
|
|
EID: 0030760517
PISSN: 00651281
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (3)
|
|
References (0)
|